India has tightened its rules on cough and cold medicine for young children, a move aimed at protecting children under 4 years of age.
In particular, it requires the manufacturers to specify that chlorpheniramine maleate and phenylephrine hydrochloride should not be used in children under four.
What has the government restricted
For the fixed-dose combinations (FDCs) containing chlorpheniramine maleate and phenylephrine hydrochloride, the FDA’s approval is not applicable.
They are commonly used in medicines that cure colds and are associated with runny or blocked nose, sneezing and other cold-related symptoms.
Under the government notification, manufacturers must have a clear warning on the medicine label, package insert and promotional material that the combination should not be used for children below four years of age.
The restriction covers the manufacture, sale and distribution of these formulations.
This was also in line with recommendations of medical experts and drug regulators that the combination could be harmful for children in this age and safer alternatives are available.
Why are young children more vulnerable
Parents often reach for cough , cold medicines when children develop symptoms, particularly during seasonal changes. But young children can respond differently to medicines because their bodies are still developing.
The use of multiple medicines without professional advice can also increase the risk of incorrect dosing or unwanted side effects.
India’s health authorities have already recommended that cough and cold medicine should not be prescribed or dispensed to children below two years and generally not recommended for children below five unless there is careful clinical evaluation.
What should parents do
Parents should avoid giving a child under four any cough or cold medicine containing the restricted combination unless specifically advised otherwise by a qualified medical professional.
The active ingredients should also be looked for in addition to the brand name. Different products can be made with the same ingredients and the combination of medicines without medical guidance is prone to accidental duplication and if not approved to be combined medicines without medical advice may result in accidental duplication of medicines.
To treat a child who has a cough or a cold, parents need to listen to the pediatrician's advice about treatment, dosage and duration. Supportive measures might be given to a child if they need fluids and care is appropriate.
Does this mean All Cough Syrups Are Banned
The latest restriction does not mean that every cough or cold medicine has been banned for children. It specifically targets fixed-dose combinations containing chlorpheniramine maleate and phenylephrine hydrochloride for children under four years.
The government’s wider goal is to ensure safer and more rational use of medicines in children. Parents should avoid self-medication and consult a healthcare professional when symptoms are persistent and severe or concerning.
The restriction is ultimately to put greater emphasis on pediatric medicine safety and prevent inappropriate use of combination cold medicines in very young children.
